This article was originally published in The Gray Sheet
Firms agree to terminate June agreement under which ANS would develop and manufacture for Sofamor Danek Group products and systems for use in deep brain stimulation ("The Gray Sheet" June 29, In Brief). "The termination agreement was agreed to by both parties due to the impending merger of SDG and Medtronic," ANS explains
You may also be interested in...
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.